Latest filing published 27 May 2021 for Abeona Therapeutics INC..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Steven H. Rouhandeh is a declared insider at 2 companies; the most frequent names are Abeona Therapeutics Inc. and Macrochem Corp. In total, 25 filings cover trades dated from 25 April 2008 to 25 May 2021.
The open-market record is one-sided, with 2 purchases worth €1.6M and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 4 share grants.
Most recently, on 27 May 2021, the filings show a share grant in Abeona Therapeutics Inc. The last insider purchase was made public on 30 December 2014, 4,316 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 5 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration